SCHEMBL26548895

SCHEMBL26548895

FC(F)(F)c1ccc(-c2ccc(-c3ccc4ccc(-c5ccc(-c6cccnc6)cc5)cc4c3)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 7/20 0.63
CYP11B1 P15538 6/20 0.63
CYP17A1 P05093 4/20 0.63
CYP19A1 P11511 4/20 0.63
DGAT1 O75907 1/20 0.58
KCNH2 Q12809 1/20 0.58
NPC1 O15118 1/20 0.56
S1PR1 P21453 1/20 0.56
KIF11 P52732 3/20 0.54
NPY5R Q15761 1/20 0.52
KDR P35968 1/20 0.51
EPHX2 P34913 1/20 0.51
FGFR1 P11362 1/20 0.48
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2A6 P11509 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548584 1.00 CYP11B2 (0.63) CYP11B2CYP11B1CYP17A1CYP19A1DGAT1
SCHEMBL26548400 0.95 CYP11B2 (0.65) CYP11B2CYP11B1CYP17A1CYP19A1DGAT1
SCHEMBL26547967 0.95 CYP11B2 (0.65) CYP11B2CYP11B1CYP17A1CYP19A1DGAT1
SCHEMBL26548587 0.91 CYP11B2 (0.59) CYP11B2CYP11B1CYP17A1CYP19A1DGAT1
SCHEMBL26548901 0.91 CYP11B2 (0.59) CYP11B2CYP11B1CYP17A1CYP19A1DGAT1
SCHEMBL26548711 0.91 CYP11B2 (0.52) CYP11B2CYP11B1CYP17A1CYP19A1DGAT1
SCHEMBL6552315 0.88 NPC1 (0.68) CYP11B2DGAT1KCNH2NPC1S1PR1
SCHEMBL22778182 0.88 NPC1 (0.68) CYP11B2DGAT1KCNH2NPC1S1PR1
SCHEMBL29468037 0.88 NPC1 (0.68) CYP11B2DGAT1KCNH2NPC1S1PR1
SCHEMBL26548403 0.86 CYP11B2 (0.61) CYP11B2CYP11B1CYP17A1CYP19A1DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 CYP11B2 1913/4885CYP11B1 1676/4885CYP17A1 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.